The share price of Hologic, Inc. [NASDAQ: HOLX] inclined by $54.24, presently trading at $53.82. The company’s shares saw 26.31% gains compared to the lowest price in the period of the last 52 weeks, set at $42.61 recorded on Jan 23, 2020. The last few days have been tough to the share price as HOLX jumped by +0.13% during the last week, even though the stock is still down by -1.66% compared to 0.07 of all time high it touched on 01/17/20. However, the stock had a strong performance during the past 3 months, roughly gaining 3.46%, while additionally gaining 21.22% during the last 12 months. Hologic, Inc. is said to have a 12-month price target set at $55.70. That means that the stock has a strong potential to acquire 1.88% increase from the current trading price.
Hologic, Inc. [NASDAQ:HOLX]: Analyst Rating and Earnings
Its stock price has been found in the range of 42.61 to 54.73. This is compared to its latest closing price of $54.24.
Keep your eyes peeled for the soon-to-be-published financial results of this company, which are expected to be made public on Wed 29 Jan (In 6 Days).
Fundamental Analysis of Hologic, Inc. [HOLX]
Now let’s turn to look at profitability: with a current Operating Margin for Hologic, Inc. [HOLX] sitting at +16.87 and its Gross Margin at +50.41, this company’s Net Margin is now -6.00%. These metrics indicate that this company is not generating as much profit, after accounting for expenses, compared to its market peers.
This company’s Return on Total Capital is 10.31, and its Return on Invested Capital has reached -1.30%. Its Return on Equity is -8.96, and its Return on Assets is -2.98. These metrics suggest that this Hologic, Inc. does a poor job of managing its assets, and likely won’t be able to provide successful business outcomes for its investors in the near term.
Turning to investigate this organization’s capital structure, Hologic, Inc. [HOLX] has generated a Total Debt to Total Equity ratio of 147.06. Similarly, its Total Debt to Total Capital is 59.52, while its Total Debt to Total Assets stands at 48.30. Looking toward the future, this publicly-traded company’s Long-Term Debt to Equity is 4.04, and its Long-Term Debt to Total Capital is 134.07.
What about valuation? This company’s Enterprise Value to EBITDA is 15.93 and its Total Debt to EBITDA Value is 3.02. The Enterprise Value to Sales for this firm is now 4.88, and its Total Debt to Enterprise Value stands at 0.20. Hologic, Inc. [HOLX] has a Price to Book Ratio of 6.28, a Price to Cash Flow Ratio of 20.58.
Shifting the focus to workforce efficiency, Hologic, Inc. [HOLX] earns $519,805 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 5.48 and its Total Asset Turnover is 0.49. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 1.26 and its Current Ratio is 1.68. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.
Hologic, Inc. [HOLX] has 268.89M shares outstanding, amounting to a total market cap of $14.47B. Its stock price has been found in the range of 42.61 to 54.73. At its current price, it has moved down by -1.66% from its 52-week high, and it has moved up 26.31% from its 52-week low.
This stock’s Beta value is currently 0.85, which indicates that it is 1.03% more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 63.34. This RSI score is good, suggesting this stock is neither overbought or oversold.
Conclusion: Is Hologic, Inc. [HOLX] a Reliable Buy?
Shares of Hologic, Inc. [HOLX], on the whole, present investors with both positive and negative signals. Wall Street analysts have mixed reviews when it comes to the 12-month price outlook, and this company’s financials show a combination of strengths and weaknesses. Based on the price performance, this investment is somewhat risky while presenting reasonable potential for ROI.